Article Details
Retrieved on: 2021-08-13 15:36:51
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The Roche study's primary endpoint is time to alleviate or improve COVID-19 symptoms maintained for 24 hours. Data from that Phase III study is ...
Article found on: www.biospace.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here